December 8, 2021 — This is a time of great change in obesity care. Right now, semaglutide is on its way to becoming a blockbuster new drug. That’s because it can help people with obesity control their condition better – with more weight loss – than older anti-obesity medicines. But at the same time, new non-drug, non-systemic options with […]
November 2, 2021 — Monday was quite an opening day for ObesityWeek 2021. Starting with the lived experience, the meeting then moved quickly into some serious science, clinical care, and policy discussions. But one of the most impressive sessions of the day gave us a “tour de force” of future options under development for obesity care. Our friend Mike […]
June 19, 2020 — In pharmaceuticals, a one-trick pony is doomed to oblivion. Some companies have a big hit with a successful drug and then struggle to follow up with more innovation. So patents expire and sales dwindle. The company with one-trick innovation fades away. But with solid clinical trial results announced yesterday for two new drugs in obesity, […]
April 16, 2019 — FDA has just cleared a new capsule for obesity care that doesn’t fit neatly into any of the sorting boxes for obesity treatment. It’s not a drug, even though it looks like one. Instead, it’s a device. It’s a capsule full of hydrogel particles that swell into a mass to help your stomach feel full […]
